title: Treatment of childhood acute nonlymphocytic leukemia with individually scheduled high doses of cytarabine: preliminary results of study ANLL-82 of the Dutch Childhood Leukemia Study Group (DCLSG).
authors.forename: K
authors.initials: K
authors.lastname: Hählen
authors.forename: A
authors.initials: A
authors.lastname: van der Does-van den Berg
authors.forename: L P
authors.initials: LP
authors.lastname: Colly
authors.forename: L A
authors.initials: LA
authors.lastname: Smets
authors.forename: J A
authors.initials: JA
authors.lastname: Taminiau
authors.forename: J M
authors.initials: JM
authors.lastname: Vossen
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D009426:Netherlands; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone